Strengthening the Stem Cell Industry Through Better Regulation
FDA should take steps to strengthen the regenerative medicine industry.
FDA Versus Our Own Stem Cells
The federal government seeks authority over stem cell treatments but risks thwarting medical advancement.
When it Comes to Federal Stem Cell Regulation, Less is More
FDA ought to promote stem cell therapy by easing up on regulation and its aggressive enforcement.